J Pharma

From its establishment in 2005, J-Pharma, a clinical stage bio-venture company with a special focus on membrane transporters, has been conducting an array of unique drug developments by Hitoshi Endou, MD., Ph.D., formerly a professor of Kyorin University Faculty of Medicine. Recently J-Pharma has been placing the highest priority on the clinical development of its original inhibitors of L-type amino acid transporter 1 (LAT1) for the treatment of advanced cancer patients who failed to benefit from standard chemotherapy

J pharma operates in the Pharmaceutical manufacturing industry.

J pharma's revenue is 11m - 100m

J pharma has 11 - 50 employees.